Search | IOVS | ARVO Journals

Showing 1 – 20 of 36

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Imaging in the Eye Conference Abstract July 2024

Baseline characterization of DRIL in Uveitic Macular Edema

Justin Bitner; Brandon Vander Zee; Amitha Domalpally; Jeong W Pak; Rick Voland; Jennifer E. Thorne; Elizabeth Sugar; Janet Holbrook; Douglas A. Jabs; Michael Altaweel

Invest. Ophthalmol. Vis. Sci.. 2024; 65(9):PB00100.

ARVO Annual Meeting Abstract June 2024

Association of DRIL with OCT Outcomes in Uveitic Macular Edema in the POINT study

Brandon Vander Zee; Sam Whittier; Amitha Domalpally; Jeong W Pak; Rick Voland; Jennifer E Thorne; Elizabeth Sugar; Janet Holbrook; Douglas A Jabs; Michael Altaweel

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1381.

ARVO Annual Meeting Abstract June 2021

Factors Predicting Success of Macular Hole Repairs

Paige Richards; Michael M Altaweel; T Michael Nork; Michael Lasarev; Jonathan Chang

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3658.

ARVO Annual Meeting Abstract July 2019

Retinal Detachment Repair Outcomes in Patients who Received Preoperative Evaluation with a Different Surgeon

Zack Oakey; Ian Holmen; Jonathan S Chang; Elaine Downie; Michael S Ip; Michael M Altaweel; Justin Gottlieb; T Michael Nork

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6588.

ARVO Annual Meeting Abstract July 2019

Recurrent retinal detachment: Surgical practices and outcomes

Elaine Downie; Zack Oakey; Ian Holmen; Michael M Altaweel; Justin Gottlieb; Michael S Ip; T Michael Nork; Jonathan S Chang

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6593.

ARVO Annual Meeting Abstract September 2016

Propranolol for Proliferative Diabetic Retinopathy

Andrew Hendrick; Jeremy Lavine; Amitha Domalpally; Amol Kulkarni; T Michael Nork; Justin Gottlieb; Ron Danis; Michael M Altaweel; Barbara A Blodi; Suresh Chandra; Michael S Ip

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6345.

ARVO Annual Meeting Abstract June 2015

Benefits of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Intraocular Implant for Intermediate, Posterior and Panuveitis: 54 month results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study

John H Kempen; Michael M Altaweel; Lea T. Drye; Janet T. Holbrook; Douglas A Jabs; Elizabeth A Sugar; Jennifer E Thorne; Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3209.

ARVO Annual Meeting Abstract June 2015

Prevalence and Risk Factors of Epiretinal membrane in the Multicenter Uveitis Steroid Treatment (MUST) Trial

Lyndell L Lim; Francis Abreu; Elizabeth A Sugar; Alyce Burke; Michael M Altaweel; P. Kumar Rao; Janet T. Holbrook; Susan G Elner; Richard Stawell; John H Kempen; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5773.

ARVO Annual Meeting Abstract June 2015

Risks and Quality of Life associated with Fluocinolone Acetonide Intraocular Implant Versus Systemic Anti-inflammatory Therapy for Intermediate, Posterior or Panuveitis: 4.5 year results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study

Michael M Altaweel; John H Kempen; Lea T. Drye; Janet T. Holbrook; Douglas A Jabs; Elizabeth A Sugar; Jennifer E Thorne; Multicenter Uveitis Steroid Treatment (MUST) Trial Follow-up Study Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5774.

ARVO Annual Meeting Abstract April 2014

Incremental Cost-Effectiveness of Fluocinolone Acetonide Implant vs Systemic Therapy for Non-infectious Intermediate, Posterior, and Pan-Uveitis

Elizabeth A Sugar; Janet T Holbrook; John H Kempen; Alyce E Burke; Lea T Drye; Jennifer E Thorne; Thomas A Louis; Douglas A Jabs; Michael M Altaweel; Kevin Frick; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5796.

ARVO Annual Meeting Abstract April 2014

Risk factors for reduced visual acuity in non-infectious intermediate, posterior, and panuveitis

Douglas A Jabs; Mark L Van Natta; Michael M Altaweel; James P Dunn; Susan Lightman; Jennifer E Thorne; Janet T Holbrook; John H Kempen; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6033.

ARVO Annual Meeting Abstract April 2014

Visual acuity outcome of non-infectious intermediate, posterior, and panuveitis in the Multicenter Uveitis Steroid Treatment (MUST) Trial

John H Kempen; Mark L Van Natta; Michael M Altaweel; James P Dunn; Douglas A Jabs; Susan Lightman; Jennifer E Thorne; Janet T Holbrook; The Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6036.

ARVO Annual Meeting Abstract June 2013

Clinical Outcomes of Eyes with Neovascular Lesions Composed of >50% Blood Treated with Anti-VEGF Therapy in the Comparison of AMD Treatments Trials (CATT)

Michael Altaweel; Juan Grunwald; Ebenezer Daniel; Gui-Shuang Ying; Jiayan Huang; Glenn Jaffe; Comparison of Age-related Macular Degeneration Treatments Trials Research Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4162.

ARVO Annual Meeting Abstract April 2011

Identifying a Clinically Meaningful Threshold for Change in Macular Edema in Patients with Uveitis

Jennifer E. Thorne; Elizabeth Sugar; Douglas A. Jabs; Michael M. Altaweel; Susan L. Lightman; Nisha Acharya; Albert T. Vitale; MUST Research Group

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4307.

ARVO Annual Meeting Abstract April 2011

The Impact Of Macular Edema On Visual Function In Uveitis

Simon R. Taylor; Sue Lightman; Elizabeth A. Sugar; Glenn J. Jaffe; William R. Freeman; Michael M. Altaweel; Igor Kozak; Janet T. Holbrook; Douglas A. Jabs; John H. Kempen

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4309.

ARVO Annual Meeting Abstract April 2011

Diagnosis of Macular Edema in Patients with Uveitis

John H. Kempen; Elizabeth A. Sugar; Nisha Acharya; James P. Dunn, Jr.; Susan G. Elner; Glenn J. Jaffe; Susan L. Lightman; Jennifer E. Thorne; Albert T. Vitale; Michael M. Altaweel

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):6564.

ARVO Annual Meeting Abstract April 2010

Morphological Assessment of Fundus Color Images for the Multicenter Uveitis Steroid Treatment (MUST) Trial

S. B. Reed; S. Gangaputra; A. Domalpally; Q. Peng; M. Altaweel; MUST Study Group

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):328.

ARVO Annual Meeting Abstract April 2010

Retinal Assessment With Optical Coherence Tomography (OCT) in the Multicenter Uveitis Steroid Treatment (MUST) Trial

M. M. Altaweel; D. Myers; A. Domalpally; MUST Study Group

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):271.

ARVO Annual Meeting Abstract April 2009

Idiopathic Pigment Epithelial Detachment Clinical Characteristics

P. N. Youssef; J. Gunther; M. Altaweel

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):758.

ARVO Annual Meeting Abstract April 2009

Morphological Assessment for Glaucoma in the Multicenter Uveitis Steroid Treatment Trial

S. B. Reed; S. Gangaputra; D. Friedman; M. M. Altaweel; MUST Trial Study Group

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5809.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Specify Date Range

Baseline characterization of DRIL in Uveitic Macular Edema

Association of DRIL with OCT Outcomes in Uveitic Macular Edema in the POINT study

Factors Predicting Success of Macular Hole Repairs

Retinal Detachment Repair Outcomes in Patients who Received Preoperative Evaluation with a Different Surgeon

Recurrent retinal detachment: Surgical practices and outcomes

Propranolol for Proliferative Diabetic Retinopathy

Benefits of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Intraocular Implant for Intermediate, Posterior and Panuveitis: 54 month results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study

Prevalence and Risk Factors of Epiretinal membrane in the Multicenter Uveitis Steroid Treatment (MUST) Trial

Risks and Quality of Life associated with Fluocinolone Acetonide Intraocular Implant Versus Systemic Anti-inflammatory Therapy for Intermediate, Posterior or Panuveitis: 4.5 year results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study

Incremental Cost-Effectiveness of Fluocinolone Acetonide Implant vs Systemic Therapy for Non-infectious Intermediate, Posterior, and Pan-Uveitis

Risk factors for reduced visual acuity in non-infectious intermediate, posterior, and panuveitis

Visual acuity outcome of non-infectious intermediate, posterior, and panuveitis in the Multicenter Uveitis Steroid Treatment (MUST) Trial

Clinical Outcomes of Eyes with Neovascular Lesions Composed of >50% Blood Treated with Anti-VEGF Therapy in the Comparison of AMD Treatments Trials (CATT)

Identifying a Clinically Meaningful Threshold for Change in Macular Edema in Patients with Uveitis

The Impact Of Macular Edema On Visual Function In Uveitis

Diagnosis of Macular Edema in Patients with Uveitis

Morphological Assessment of Fundus Color Images for the Multicenter Uveitis Steroid Treatment (MUST) Trial

Retinal Assessment With Optical Coherence Tomography (OCT) in the Multicenter Uveitis Steroid Treatment (MUST) Trial

Idiopathic Pigment Epithelial Detachment Clinical Characteristics

Morphological Assessment for Glaucoma in the Multicenter Uveitis Steroid Treatment Trial

To View More...

You must be signed into an individual account to use this feature.